T. Rowe Price Investment Management »

Centessa Pharmaceuticals shares owned by T. Rowe Price Investment Management

Quarter-by-quarter ownership of Centessa Pharmaceuticals (CNTA) shares owned by T. Rowe Price Investment Management from 13F filings

Historical chart of T. Rowe Price Investment Management investment in Centessa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Centessa Pharmaceuticals held by T. Rowe Price Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Centessa Pharmaceuticals by T. Rowe Price Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $57M 3.6M 15.99
2024-06-30 $7.5M 834k 9.03

More positions owned by T. Rowe Price Investment Management

Microsoft Corp Comm Stk (MSFT)
Nvidia Corporation Comm Stk (NVDA)
Fortive Corp Comm Stk (FTV)
Amazon Comm Stk (AMZN)
PTC Comm Stk (PTC)
Unitedhealth Group Comm Stk (UNH)
Revvity Comm Stk (RVTY)
Danaher Corporation Comm Stk (DHR)
Becton Dickinson & Co Comm Stk (BDX)
Roper Technologies Comm Stk (ROP)
Marvell Technology Comm Stk (MRVL)
Martin Marietta Matls Comm Stk (MLM)
Alphabet Comm Stk (GOOGL)
Apple Comm Stk (AAPL)
Hologic Comm Stk (HOLX)

View all positions for T. Rowe Price Investment Management

Top funds holding Centessa Pharmaceuticals

Medicxi Ventures Management
General Atlantic
Perceptive Advisors
First Light Asset Management
EcoR1 Capital
T. Rowe Price Associates
Vida Ventures Advisors
T. Rowe Price Investment Management
Siren
TCG Crossover Management
Point72 Asset Management
Franklin Resources
Driehaus Capital Management
Avidity Partners Management
Morgan Stanley

View all funds holding Centessa Pharmaceuticals